Background parenchymal enhancement at breast MR imaging: Normal patterns, diagnostic challenges, and potential for false-positive and false-negative interpretation

Radiographics

Volumn 34, Issue 1, 2014, Pages 234-247

  Giess, Catherine S ^a   Yeh, Eren D ^a   Raza, Sughra ^a   Birdwell, Robyn L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ADULT; AGED; ALGORITHM; BREAST; BREAST TUMOR; DIAGNOSTIC ERROR; DIAGNOSTIC USE; FEMALE; HUMAN; IMAGE ENHANCEMENT; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREVENTION AND CONTROL; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

ADULT; AGED; ALGORITHMS; BREAST; BREAST NEOPLASMS; CONTRAST MEDIA; DIAGNOSTIC ERRORS; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84892688735     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.341135034     Document Type: Review

References (39)

1. Morris EA. Diagnostic breast MR imaging: current status and future directions. Radiol Clin North Am 2007;45(5):863-880, vii.
2. Ikeda DM, Hylton NM, Kuhl CK, et al. BI-RADS: magnetic resonance imaging, 1st ed. In: D'Orsi CJ, Mendelson EB, Ikeda DM, et al, eds. Breast Imaging Reporting and Data System: ACR BI-RADS-breast imaging atlas. Reston, Va: American College of Radiology, 2003; 1-114.
3. Kuhl CK, Bieling HB, Gieseke J, et al. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 1997;203(1):137-144.
4. Giess CS, Raza S, Birdwell RL. Patterns of nonmasslike enhancement at screening breast MR imaging of high-risk premenopausal women. RadioGraphics 2013;33(5):1343-1360.
5. Kuhl C. The current status of breast MR imaging. I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 2007;244(2):356-378.
6. Romrell LJ, Bland KI. Anatomy of the breast, axilla, chest wall, and related metastatic sites. In: Bland KI, Copeland EM III, eds. The breast: comprehensive management of benign and malignant disorders. 3rd ed. Philadelphia, Pa: Saunders, 2004; 21-42.
7. Birdwell RL, Raza S, Odulate AS. NMLE: diffuse, background enhancement. In: Raza S, Birdwell RL, eds. Specialty imaging: breast MRI-a comprehensive imaging guide. Salt Lake City, Utah: Amirsys, 2010; II-3-84-II-3-99.
8. Müller-Schimpfle M, Ohmenhaüser K, Stoll P, Dietz K, Claussen CD. Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology 1997; 203(1):145-149.
9. Delille JP, Slanetz PJ, Yeh ED, Kopans DB, Garrido L. Physiologic changes in breast magnetic resonance imaging during the menstrual cycle: perfusion imaging, signal enhancement, and influence of the T1 relaxation time of breast tissue. Breast J 2005;11(4): 236-241.
10. Ellis RL. Optimal timing of breast MRI examinations for premenopausal women who do not have a normal menstrual cycle. AJR Am J Roentgenol 2009;193(6):1738-1740.
11. Talele AC, Slanetz PJ, Edmister WB, Yeh ED, Kopans DB. The lactating breast: MRI findings and literature review. Breast J 2003;9(3):237-240.
12. Espinosa LA, Daniel BL, Vidarsson L, Zakhour M, Ikeda DM, Herfkens RJ. The lactating breast: contrast-enhanced MR imaging of normal tissue and cancer. Radiology 2005;237(2):429-436.
13. Taylor D, Lazberger J, Ives A, Wylie E, Saunders C. Reducing delay in the diagnosis of pregnancy-associated breast cancer: how imaging can help us. J Med Imaging Radiat Oncol 2011;55(1):33-42.
14. Kubik-Huch RA, Gottstein-Aalame NM, Frenzel T, et al. Gadopentetate dimeglumine excretion into human breast milk during lactation. Radiology 2000; 216(2):555-558.
15. American College of Radiology manual on contrast media, version 8, 2012; 79-80. http://www.nxtbook.com/nxtbooks/acr/contrastmediamanual2012/. Accessed March 5, 2013.
16. King V, Gu Y, Kaplan JB, Brooks JD, Pike MC, Morris EA. Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI. Eur Radiol 2012;22(12): 2641-2647.
17. Pfleiderer SOR, Sachse S, Sauner D, et al. Changes in magnetic resonance mammography due to hormone replacement therapy. Breast Cancer Res 2004; 6(3):R232-R238.
18. Delille JP, Slanetz PJ, Yeh ED, Kopans DB, Halpern EF, Garrido L. Hormone replacement therapy in postmenopausal women: breast tissue perfusion determined with MR imaging-initial observations. Radiology 2005;235(1):36-41.
19. King V, Kaplan J, Pike MC, et al. Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging. Breast J 2012;18(6): 527-534.
20. Oksa S, Parkkola R, Luukkaala T, Mäenpää J. Breast magnetic resonance imaging findings in women treated with toremifene for premenstrual mastalgia. Acta Radiol 2009;50(9):984-989.
21. King V, Goldfarb SB, Brooks JD, et al. Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging. Radiology 2012;264(3): 670-678.
22. Mousa NA, Eiada R, Crystal P, Nayot D, Casper RF. The effect of acute aromatase inhibition on breast parenchymal enhancement in magnetic resonance imaging: a prospective pilot clinical trial. Menopause 2012;19(4):420-425.
23. Cubuk R, Tasali N, Narin B, Keskiner F, Celik L, Guney S. Correlation between breast density in mammography and background enhancement in MR mammography. Radiol Med (Torino) 2010;115 (3):434-441.
24. Ko ES, Lee BH, Choi HY, Kim RB, Noh WC. Background enhancement in breast MR: correlation with breast density in mammography and background echotexture in ultrasound. Eur J Radiol 2011;80(3):719-723.
25. Hambly NM, Liberman L, Dershaw DD, Brennan S, Morris EA. Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up. AJR Am J Roentgenol 2011;196(1):218-224.
26. Uematsu T, Kasami M, Watanabe J. Should breast MRI be performed with adjustment for the phase in patients' menstrual cycle? Correlation between mammographic density, age, and background enhancement on breast MRI without adjusting for the phase in patients' menstrual cycle. Eur J Radiol 2012;81(7):1539-1542.
27. Agrawal G, Su MY, Nalcioglu O, Feig SA, Chen JH. Significance of breast lesion descriptors in the ACR BI-RADS MRI lexicon. Cancer 2009;115(7): 1363-1380.
28. Abramovici G, Mainiero MB. Screening breast MR imaging: comparison of interpretation of baseline and annual follow-up studies. Radiology 2011;259 (1):85-91.
29. Jansen SA, Lin VC, Giger ML, Li H, Karczmar GS, Newstead GM. Normal parenchymal enhancement patterns in women undergoing MR screening of the breast. Eur Radiol 2011;21(7):1374-1382.
30. King V, Brooks JD, Bernstein JL, Reiner AS, Pike MC, Morris EA. Background parenchymal enhancement at breast MR imaging and breast cancer risk. Radiology 2011;260(1):50-60.
31. Thomassin-Naggara I, Trop I, Chopier J, et al. Nonmasslike enhancement at breast MR imaging: the added value of mammography and US for lesion categorization. Radiology 2011;261(1):69-79.
32. Chen JH, Liu H, Baek HM, Nalcioglu O, Su MY. Magnetic resonance imaging features of fibrocystic change of the breast. Magn Reson Imaging 2008;26 (9):1207-1214.
33. Li J, Dershaw DD, Lee CH, Joo S, Morris EA. Breast MRI after conservation therapy: usual findings in routine follow-up examinations. AJR Am J Roentgenol 2010;195(3):799-807.
34. Brennan SB, Sung JS, Dershaw DD, Liberman L, Morris EA. Cancellation of MR imaging-guided breast biopsy due to lesion nonvisualization: frequency and follow-up. Radiology 2011;261(1): 92-99.
35. DeMartini WB, Liu F, Peacock S, Eby PR, Gutierrez RL, Lehman CD. Background parenchymal enhancement on breast MRI: impact on diagnostic performance. AJR Am J Roentgenol 2012;198(4): W373-W380.
36. Houssami N, Morrow M. Pre-operative breast MRI in women with recently diagnosed breast cancer: where to next? Breast 2010;19(1):1-2.
37. Teifke A, Hlawatsch A, Beier T, et al. Undetected malignancies of the breast: dynamic contrast-enhanced MR imaging at 1.0 T. Radiology 2002;224 (3):881-888.
38. Shimauchi A, Jansen SA, Abe H, Jaskowiak N, Schmidt RA, Newstead GM. Breast cancers not detected at MRI: review of false-negative lesions. AJR Am J Roentgenol 2010;194(6):1674-1679.
39. Uematsu T, Kasami M, Watanabe J. Does the degree of background enhancement in breast MRI affect the detection and staging of breast cancer? Eur Radiol 2011;21(11):2261-2267.